Guardant Health, Inc. (GH): Capital Expenditures
$48.31M
Year ended 2025-12-31
$55.54M
Trailing 12 months to 2026-06-30
-14.6%
3-year compound annual growth
+6.0%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $48.31M | +37.7% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $35.09M | +71.3% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $20.49M | -73.6% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $77.46M | +3.2% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $75.03M | +107.4% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $36.17M | +93.3% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $18.72M | -7.4% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $20.20M | +202.4% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $6.68M | +278.3% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $1.77M | n/a | 2019-03-19, From 2016-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Guardant Health, Inc. (GH) | 2025-12-31 | $48.31M | +37.7% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $16.26M | +92.6% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $9.68M | -14.3% |
| Natera, Inc. (NTRA) | 2025-12-31 | $106.19M | +59.9% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $25.20M | -1.2% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $36.02M | +27.2% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $22.57M | -44.0% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $8.88M | +64.4% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $909.0K | -82.5% |
Compare GH, CAI, VCYT, NTRA side by side · Screen every company in Services-Medical Laboratories ↗